BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chopra D, Bhandari B. Sofosbuvir: Really Meets the Unmet Needs for Hepatitis C Treatment? Infect Disord Drug Targets 2020;20:2-15. [PMID: 30113002 DOI: 10.2174/1871526518666180816101124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Chang R, Xu ST, Jin HW, Zhao YJ, Hu TY, Wang G, Wang J, Zhen L. Simultaneous determination of ZL-01, a novel nucleotide prodrug, and its metabolites in rat plasma by LC-MS/MS: Application to pharmacokinetic study. J Pharm Biomed Anal 2022;208:114437. [PMID: 34735992 DOI: 10.1016/j.jpba.2021.114437] [Reference Citation Analysis]
2 Song W, Zhang H, Zhang Y, Li R, Han Y, Lin Y, Jiang J. Repurposing clinical drugs is a promising strategy to discover drugs against Zika virus infection. Front Med 2021;15:404-15. [PMID: 33369711 DOI: 10.1007/s11684-021-0834-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Han Y, Mesplède T. Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update. Expert Opin Investig Drugs 2018;27:951-62. [PMID: 30430882 DOI: 10.1080/13543784.2018.1548609] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]